Our analysis supports the potential use of ELISA-measured urinary KIM-1 as an early renal injury marker in low-level cadmium exposure for CKD patients, whose optimal biomarker for cadmium-induced nephrotoxicity has not yet been defined. Here, HAVCR1 is linked to chronic kidney disease.